Endovia Health Sciences EDVA
NYSE EDVA
$0.26 +0.00 (+0.00%)
As of: Sep 3, 2026 · 11:52 AM EDT

Endovia Health Sciences (EDVA) Long-Term Deferred Tax (2012 - 2025)

Analysis

Endovia Health Sciences (EDVA) Long-Term Deferred Tax (2012 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.50 Bn 133.65 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn
3 Argenx Se 65.05 Bn 59.86 Bn 1.37 Bn
4 Moderna 57.11 Bn 51.98 Bn 52.00 Mn
5 Revolution Medicines 44.71 Bn 44.71 Bn -
6 BeOne Medicines 40.40 Bn 35.31 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.36 Bn 32.05 Bn 992.69 Mn
8 Royalty Pharma 28.16 Bn 27.32 Bn -
9 Insmed 27.40 Bn 26.24 Bn 358.27 Mn
10 Endovia Health Sciences 801,166.21 558,464.21 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 37.90 Mn
Dec 31, 2024 33.70 Mn
Dec 31, 2023 29.13 Mn
Dec 31, 2022 24.02 Mn
Dec 31, 2021 19.58 Mn
Dec 31, 2020 13.58 Mn
Dec 31, 2019 6.85 Mn
Dec 31, 2018 149,000.00
Jun 30, 2018 220,000.00
Dec 31, 2017 220,000.00
Dec 31, 2015 7,350.00
Dec 31, 2013 7,500.00
Dec 31, 2012 1,300.00